Simplex Trading
ALXO icon

Simplex Trading’s ALX Oncology ALXO Stock Holding History

Simplex Trading’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.8K Sell
5,400
-2,600
-33% -$4.95K ﹤0.01% 7295
2025
Q4 		$9.04K Sell
8,000
-43,900
-85% -$66.5K ﹤0.01% 7048
2025
Q3 		$94K Sell
51,900
-11,700
-18% -$10.1K ﹤0.01% 5813
2025
Q2 		$26K Buy
63,600
+59,900
+1,619% +$30.2K ﹤0.01% 6519
2025
Q1 		$2K Sell
3,700
-800
-18% -$960 ﹤0.01% 7920
2024
Q4 		$7K Sell
4,500
-22,500
-83% -$34.6K ﹤0.01% 7388
2024
Q3 		$49K Buy
27,000
+800
+3% +$2.97K ﹤0.01% 5894
2024
Q2 		$157K Buy
26,200
+18,900
+259% +$232K ﹤0.01% 4890
2024
Q1 		$81K Buy
7,300
+300
+4% +$4.21K ﹤0.01% 5795
2023
Q4 		$104K Buy
+7,000
New +$66.4K ﹤0.01% 5341
2023
Q3 		– Sell
-7,100
Closed -$53K – 8559
2023
Q2 		$53K Buy
7,100
+3,200
+82% +$20.9K ﹤0.01% 5782
2023
Q1 		$17K Buy
3,900
+3,500
+875% +$26.5K ﹤0.01% 7041
2022
Q4 		$4K Sell
400
-5,800
-94% -$65.1K ﹤0.01% 8162
2022
Q3 		$59K Sell
6,200
-7,700
-55% -$89.7K ﹤0.01% 6201
2022
Q2 		$112K Buy
13,900
+13,400
+2,680% +$146K ﹤0.01% 5414
2022
Q1 		$8K Buy
500
+100
+25% +$1.71K ﹤0.01% 9022
2021
Q4 		$8K Sell
400
-10,000
-96% -$431K ﹤0.01% 9172
2021
Q3 		$582K Buy
10,400
+100
+1% +$6.67K ﹤0.01% 3859
2021
Q2 		$563K Buy
10,300
+10,254
+22,291% +$614K ﹤0.01% 3957
2021
Q1 		$339K Buy
46
+45
+4,500% +$3.54K ﹤0.01% 3981
2020
Q4 		$8K Buy
+1
New +$60 ﹤0.01% 7502

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Simplex Trading's ALXO Position: Q1 2026 in Review

Simplex Trading sold out of ALX Oncology (ALXO) in Q1 2026, closing a stake of 3,553 shares — an estimated $6.77K sold.

Simplex Trading first reported a position in ALXO in Q1 2021 and held it in 10 quarters. The position peaked at $117K in Q4 2023. 69 funds tracked by Wall St. Rank hold ALXO as of Q1 2026.

  • Simplex Trading reported no remaining ALX Oncology position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 3,553 ALX Oncology shares in Q1 2026, an estimated $6.77K.
  • Simplex Trading first reported a position in ALX Oncology in Q1 2021 and held it in 10 quarters.
  • Simplex Trading's ALX Oncology position peaked at $117K in Q4 2023.
  • 69 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.